Microbiology & Infectious Diseases

Infectious diseases physicians and public health professionals are essential partners in preparing for and responding to public health emergencies, according to new research that highlights lessons learned during the COVID-19 pandemic.

In a large multi-year surveillance study conducted across seven US medical centers, researchers found that respiratory syncytial virus (RSV) co-detection with other respiratory viruses in children under 2 years old was not significantly associated with worse clinical outcomes.

Kaposi sarcoma-associated herpesvirus (KSHV) is widespread among HIV-positive kidney transplant patients and donors in the United States, but KSHV-related disease remains rare, according to new research.

New research explores how virus-specific T-cell therapy may help prevent or treat cytomegalovirus after transplant, revealing high response rates in HSCT patients but limited data in solid organ recipients.

The targeted use of local antibiotics in orthopedic surgery is gaining traction, but limited supporting evidence continues to challenge its widespread adoption, according to a new review exploring current practices and novel technologies in infection management.

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term neurological impact, with metagenomic sequencing crucial for diagnosis.

Pregnancy alters the immune system, increasing susceptibility to infections like Pneumocystis jirovecii, an opportunistic fungus known for causing severe pneumonia in immunocompromised individuals.

Fecal microbiota transplantation (FMT), an emerging therapy for conditions like irritable bowel syndrome (IBS), continues to raise questions about the safety of transferring certain microorganisms, especially the intestinal parasite Blastocystis spp.